Résumé
BACKGROUND: Platelets play a central role in hemostatic and inflammatory responses during septic shock, with lipids being essential for their function. However, the specific lipidomic alterations occurring in platelets during septic shock remain poorly understood.
OBJECTIVES: This study aimed to characterize platelet lipidomic changes in septic shock and investigate their associations with disease severity.
METHODS: In this matched case-control study, platelets were isolated from 49 septic shock patients and 47 nonseptic controls (matched for age, gender, and comorbidities). Lipidomic profiling was performed using untargeted lipidomics to identify significant alterations in the platelet lipidome. Associations among lipid changes, clinical data, and plasma biomarkers of coagulopathy and inflammation were explored.
RESULTS: More than 60% of the annotated platelet lipids were significantly altered in septic shock. Cholesteryl esters, sphingomyelins, lysophosphatidylcholines, and ether-lipids were significantly reduced, while ceramide levels increased. Fatty acyl chain remodeling displayed distinct patterns, with polyunsaturated fatty acids increasing in triacylglycerols and decreasing in phospholipids. Lipid alterations were strongly associated with thrombocytopenia, and lysophosphatidylcholine levels inversely correlated with disease severity, as indicated by the Sequential Organ Failure Assessment score.
CONCLUSIONS: Septic shock induces significant disruptions in the platelet lipidome, with the extent of these alterations correlating with sepsis-associated thrombocytopenia severity. The observed changes affect multiple lipid classes, surpassing those reported under physiological conditions or in other diseases. These findings highlight the impact of sepsis-driven dysregulated inflammation and coagulopathy on platelet lipid composition, providing new insights into sepsis pathophysiology.
| langue originale | Anglais |
|---|---|
| Numéro d'article | 103332 |
| Pages (de - à) | 103332 |
| journal | Research and Practice in Thrombosis and Haemostasis |
| Volume | 10 |
| Numéro de publication | 1 |
| Les DOIs | |
| Etat de la publication | Publié - janv. 2026 |
Financement
This work was supported by grants from the “Fondation Saint- Luc” (Brussels, Belgium) and the “Fonds National de la Recherche Scientifique et Médicale” (FNRS, Belgium). The Division of Cardiology at “Cliniques Universitaires Saint-Luc” (Belgium) has received unrestricted research grants from AstraZeneca (Belgium). E.d.C.d. is supported by a PhD fellowship from the FNRS. M. Dechamps is Clinical Master Specialist and a PhD candidate funded by the FNRS. S.H. is senior research associate at FNRS. QUALIblood s.a. provided the cytokine profile analyses.
| Bailleurs de fonds |
|---|
| Fonds National de la Recherche Scientifique et Médicale |
| Cliniques Universitaires Saint-Luc |
| Fondation Saint |
| Fonds De La Recherche Scientifique - FNRS |
| AstraZeneca NV |
SDG des Nations Unies
Ce résultat contribue à ou aux Objectifs de développement durable suivants
-
SDG 5 Égalité des sexes
Empreinte digitale
Examiner les sujets de recherche de « Platelet lipidome alterations in septic shock: a matched case-control study ». Ensemble, ils forment une empreinte digitale unique.Presse/médias
-
Catholic University Louvain (UCLouvain) Researchers Report on Findings in Sepsis (Platelet lipidome alterations in septic shock: a matched case-control study)
Douxfils, J., Haguet, H. & Beauloye, C.
3/02/26
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
Contient cette citation
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver